Sheevam Shah, MD
Dermatology · Cypress, TXNPI 1255787529
Payments from drug & device makers
Across 1,467 payments — averaging $331.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$125K
- Galderma Laboratories, L.p.$102K
- UCB, Inc.$66K
- Lilly USA, LLC$52K
- Dermavant Sciences, Inc.$50K
- Organon$30K
- plus $62K from 25 others
What the payments were for
- Consulting fees$63,45513%
- Speaking & faculty fees$349,53472%
- Travel & lodging$45,1839%
- Food & beverage$27,4976%
- Education$6360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 175 | $124,673 |
| Galderma Laboratories, L.p. | 141 | $101,732 |
| UCB, Inc. | 102 | $65,740 |
| Lilly USA, LLC | 107 | $52,430 |
| Dermavant Sciences, Inc. | 104 | $50,065 |
| Organon | 53 | $29,731 |
| Novartis | 140 | $15,228 |
| Johnson & Johnson | 64 | $12,111 |
| Sun Pharmaceutical Industries Inc. | 59 | $9,044 |
| Sanofi | 40 | $7,374 |
| Incyte Corporation | 63 | $6,294 |
| Arcutis Biotherapeutics, Inc. | 41 | $4,683 |
| AbbVie(2 entities) | 125 | $2,461 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,328 |
| LEO Pharma Inc. | 36 | $985 |
| Amgen | 38 | $655 |
| Mayne Pharma Commercial LLC | 85 | $517 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 20 | $232 |
| Pfizer | 13 | $216 |
| Stryker | 1 | $170 |
| Merz North America, Inc. | 1 | $130 |
| Bristol Myers Squibb | 1 | $91 |
| Almirall LLC | 4 | $79 |
| Eli Lilly | 1 | $79 |
| Revance Therapeutics, Inc. | 2 | $77 |
| Botanix SB Inc | 3 | $58 |
| EPI Health, LLC | 2 | $49 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $24 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Journey Medical Corporation | 1 | $16 |
| Dermira, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$486,304 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 19 | $76,546 |
| Dupixent SyringeDupilumab | 12 | $52,955 |
| Fluorouracil | 50 | $3,288 |
| Clobetasol Propionate | 83 | $3,041 |
| Metronidazole | 17 | $1,243 |
| ValacyclovirValacyclovir Hcl | 27 | $1,232 |
| Tacrolimus | 18 | $1,054 |
| Ketoconazole | 102 | $1,023 |
| Doxycycline Hyclate | 49 | $928 |
| Dutasteride | 27 | $628 |
| Clindamycin Phosphate | 20 | $454 |
| Fluocinonide | 14 | $423 |
| Triamcinolone Acetonide | 73 | $390 |
| Nystatin | 30 | $342 |
| Gabapentin | 16 | $269 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cypress
- Lauren CampbellCypress$2.2M
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.